FDA Announces Steps to Protect Rx Drug Supply Chain

July 21, 2017, 7:57 PM UTC

The FDA is launching a drug tracking pilot program and hosting public meetings to enhance drug security and comply with federal requirements.

The Drug Supply Chain Security Act (DSCSA) (Title II, Pub. L. 113-54), which was signed into law in 2013, outlines a 10-year plan to build an electronic, interoperable system by 2023 to trace certain prescription drugs distributed within the U.S., including starting a pilot program and hosting public meetings for feedback. The Food and Drug Administration issued the documents about the pilot program and meetings in the July 20 Federal Register (82 Fed. Reg. 33,497 ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.